Drug-induced liver disease.
暂无分享,去创建一个
[1] P. Watkins. Role of Cytochromes P45O in Drug Metabolism and Hepatotoxicity , 1990, Seminars in liver disease.
[2] S. Spielberg,et al. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. , 1988, The Journal of clinical investigation.
[3] E. Mays,et al. Hepatic Tumors Induced by Sex Steroids , 1984, Seminars in liver disease.
[4] C. McDonald,et al. Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee. , 1991, BMJ.
[5] A. V. Pollock,et al. Stones, lithotripters, trials, and arguments , 1986 .
[6] C. S. Davidson,et al. The management of fulminant hepatic failure. , 1970, Progress in liver diseases.
[7] T. Shikata,et al. Phospholipid fatty liver: a report of three cases with a new type of fatty liver. , 1970, The Japanese journal of experimental medicine.
[8] D. Bouscary,et al. Danazol-induced hepatocellular adenoma. , 1990, The American journal of medicine.
[9] D. Forman,et al. Oral contraceptives and hepatocellular carcinoma. , 1986, British medical journal.
[10] V. Hawthorne,et al. SCREENING FOR DISEASE , 1975, The Lancet.
[11] A. Klopper,et al. Hepatotoxicity of drugs. , 1962, Lancet.
[12] E. McLean. The toxic actions of pyrrolizidine (senecio) alkaloids. , 1970, Pharmacological reviews.
[13] J. Boyer,et al. Peliosis Hepatis Associated with Androgenic-Anabolic Steroid Therapy: A Severe Form of Hepatic Injury , 1974 .
[14] G. Danan,et al. Drug‐induced hepatitis associated with anticytoplasmic organelle autoantibodies , 1985, Hepatology.
[15] R. Campbell,et al. Reye's Syndrome and Medication Use , 1982 .
[16] J. Bloomer,et al. Nodular regenerative hyperplasia of the liver following bone marrow transplantation , 1989, Hepatology.
[17] F. Mullick,et al. HEPATIC AND CEREBRAL PATHOLOGY FINDINGS IN CHILDREN WITH FATAL SALICYLATE INTOXICATION: FURTHER EVIDENCE FOR A CAUSAL RELATION BETWEEN SALICYLATE AND REYE'S SYNDROME , 1983, The Lancet.
[18] A. Forbes,et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. , 1991, BMJ.
[19] J. Tredger,et al. Hepatotoxicity to sodium valproate: a review. , 1984, Gut.
[20] B. H. Ch. Stricker,et al. Drug-induced Hepatic Injury , 1985 .
[21] P. Ridker,et al. Hepatic venocclusive disease associated with the consumption of pyrrolizidine-containing dietary supplements. , 1985, Gastroenterology.
[22] R. Lüllmann-Rauch,et al. Drug-induced phospholipidoses. II. Tissue distribution of the amphiphilic drug chlorphentermine. , 1975, CRC critical reviews in toxicology.
[23] H. Zimmerman. Effects of aspirin and acetaminophen on the liver. , 1981, Archives of internal medicine.
[24] K. Ishak,et al. 11 Drug-induced and toxic granulomatous hepatitis , 1988 .
[25] J. Hoofnagle,et al. Reye's syndrome-like illness in a patient receiving amiodarone. , 1988, The American journal of gastroenterology.
[26] D. Valla,et al. Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A case-control study. , 1986, Gastroenterology.
[27] M. Mitchell,et al. Additive protection of cimetidine and N-acetylcysteine treatment against acetaminophen-induced hepatic necrosis in the rat. , 1985, The Journal of pharmacology and experimental therapeutics.
[28] J. Boyer,et al. Hepatic injury from chronic hypervitaminosis a resulting in portal hypertension and ascites. , 1974, The New England journal of medicine.
[29] G. Gordon,et al. Predisposition to phenytoin hepatotoxicity assessed in vitro. , 1981, The New England journal of medicine.
[30] K. Ishak,et al. Phenylbutazone liver injury: A clinical‐pathologic survey of 23 cases and review of the literature , 1981, Hepatology.
[31] D. Dhumeaux,et al. Drug-induced vascular lesions of the liver. , 1983, Archives of internal medicine.
[32] D. Harrison,et al. Idiopathic portal hypertension associated with cytotoxic drugs. , 1990, Journal of clinical pathology.
[33] M. Dougados,et al. Hepatocellular carcinoma after danazol therapy. , 1988, The Journal of rheumatology.